Literature DB >> 26870423

Crystal structure of (E)-13-(pyrimidin-5-yl)parthenolide.

Shobanbabu Bommagani1, Narsimha R Penthala1, Sean Parkin2, Peter A Crooks1.   

Abstract

The title compound, C19H22N2O3, {systematic name (1aR,4E,7aS,8E,10aS,10bR)-1a,5-dimethyl-8-[(pyrimidin-5-yl)-methylid-ene]-2,3,6,7,7a,8,10a,10b-octa-hydro-oxireno[2',3':9,10]cyclo-deca-[1,2-b]furan-9(1aH)-one} was obtained from the reaction of parthenolide [systematic name (1aR,7aS,10aS,10bR,E)-1a,5-dimethyl-8-methyl-ene-2,3,6,7,7a,8,10a,10b-octa-hydro-oxireno[2',3':9,10]cyclodeca-[1,2-b]furan-9(1aH)-one] with 5-bromo-pyrimidine under Heck reaction conditions, and was identified as an E isomer. The mol-ecule possesses ten-, five- (lactone) and three-membered (epoxide) rings with a pyrimidine group as a substituent. The ten-membered ring displays an approximate chair-chair conformation, while the lactone ring shows a flattened envelope-type conformation. The dihedral angle between the pyrimidine moiety and the lactone ring system is 29.43 (7)°.

Entities:  

Keywords:  Heck product; crystal structure; parthenolide; pyrimidine

Year:  2015        PMID: 26870423      PMCID: PMC4719832          DOI: 10.1107/S2056989015021507

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

Parthenolide (PTL) is a sesquiterpene lactone known to significantly target cancer stem cells, which are the putative roots of all types of cancer (Gopal et al., 2007 ▸). PTL has been isolated from several different plant species, feverfew leaf (Tanacetum parthenium) being one of the major sources (Awang, 1989 ▸). PTL exhibits a wide range of biological activities, such as anti-inflammatory, anti-bacterial, anti-fungal, and cytotoxic properties (Picman, 1986 ▸). Consequently, PTL was discovered to be capable of inducing robust apoptosis in primary acute myelogenous leukemia (AML) cells (Guzman et al., 2007 ▸), proving to be equally effective among all subpopulations within primary AML specimens, including leukemia stem cells (LSCs). Gopal et al. (2007 ▸) reported that PTL specifically depletes HDAC1 protein without affecting other class I/II HDACs (histone de­acetyl­ases). Nasim et al. (2008 ▸) reported the anti-leukemic activity of amino­parthenolide analogues. Han et al. (2009 ▸) reported on bioactive derivatives of Heck products of PTL. Recently, Penthala et al. (2014a ▸) reported the anti-cancer activity of PTL–Heck products. Recently we (Penthala et al., 2014b ▸) reported the crystal structure of 13-{4-[Z–2-cyano-2-(3,4,5-tri­meth­oxy­phen­yl)ethen­yl]phen­yl} parthenolide, an analog of PTL, which was found to have the E configuration at C-13. The inter­esting biological properties of PTL directed our attention to design and synthesize additional bioactive derivatives. In order to obtain detailed information on the structural conformation of the current mol­ecule, including assignment of the absolute configuration of the four stereocentres, and to establish the geometry of the exocyclic double bond, a single crystal X-ray structure determination has been carried out.

Structural commentary

The title compound is shown in Fig. 1 ▸. The PTL substructure of the mol­ecule contains a ten-membered carbocyclic ring (chair–chair conformation) fused to a lactone ring (flattened envelope-type conformation), and an epoxide ring, as previously reported (Castañeda-Acosta & Fisher, 1993 ▸). The title compound contains an E-exocyclic olefinic bond C11=C13. The pyrimidine ring is twisted out of the plane of the furan ring, making a dihedral angle of 29.43 (7)°. The C11=C13—C16 bond angle of 127.89 (16)° deviates from the ideal value of 120°, but other bond lengths and angles are largely unremarkable. The four chiral carbon atoms in PTL were determined using 1354 quotients (Parsons et al., 2013 ▸) as follows: C4(R),C5(R),C6(S),C7(S) for the arbitrary atom-numbering scheme used, and is consistent with previous studies (Penthala et al., 2013 ▸).
Figure 1

The mol­ecular structure of the title compound with probability ellipsoids drawn at the 50% probability level.

Supra­molecular features

There are no classical hydrogen bonds and no π–π inter­actions. There are a few C—H⋯N and C—H⋯O short contacts, but none that have the right geometry to be considered as non-classical hydrogen bonds. Inter­molecular contacts thus appear to be limited to van der Waals inter­actions.

Database survey

A search of the November 2014 release of the Cambridge Structure Database (Groom & Allen, 2014 ▸) for the PTL substructure gave 24 hits. Two of these (PARTEN: Quick & Rogers, 1976 ▸; PARTEN01: Bartsch et al., 1983 ▸) give the structure of PTL itself, with the remaining 22 being substituted variants of PTL. Of these substituted parthenolides, only four CSD entries: HORZOF (Penthala et al., 2014b ▸), HUKLAB, HUKLEF (Han et al., 2009 ▸) and QILGEZ (Penthala et al., 2013 ▸), are substituted at the exocyclic double bond.

Synthesis and crystallization

Synthetic procedures: The title compound, containing the PTL substructure, was synthesized by the previously reported literature procedure (Han et al., 2009 ▸). In brief, parthenolide (1 mmol), 5-bromo­pyrimidine (1.1 mmol), tri­ethyl­amine (3.0 mmol) and 5 mol% of palladium acetate were charged into di­methyl­formamide (2 ml) at room temperature. The reactants were stirred at 333–343 K for 24 h. After completion of the reaction, the reaction mass was extracted into diethyl ether (2 × 30 ml). The combined organic layers were dried over anhydrous sodium sulfate, concentrated and purified by column chromatography. The title compound was recrystallized from a mixture of hexane and acetone (9:1), which gave colourless needles upon slow evaporation of the solution at room temperature over 24 h.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 1 ▸. H atoms were found in difference Fourier maps, but subsequently included in the refinement using riding models, with constrained distances set to 0.95 Å (Csp 2H), 0.98 Å (RCH3), 0.99 Å (R 2CH2) and 1.00 Å (R 3CH). U iso(H) parameters were set to values of either 1.2U eq or 1.5U eq (RCH3 only) of the attached atom. The absolute structure parameter [−0.04 (3)] was determined directly from the diffraction data using 1354 Parsons quotients (Parsons et al., 2013 ▸), with the four chiral carbon atoms assigned to be R,R,S,S for the arbitrarily numbered atoms C4, C5, C6, C7, respectively.
Table 1

Experimental details

Crystal data
Chemical formulaC19H22N2O3
M r 326.38
Crystal system, space groupMonoclinic, P21
Temperature (K)90
a, b, c (Å)10.3526 (2), 7.2612 (1), 11.9198 (2)
β (°)108.1210 (6)
V3)851.60 (2)
Z 2
Radiation typeCu Kα
μ (mm−1)0.70
Crystal size (mm)0.25 × 0.13 × 0.10
 
Data collection
DiffractometerBruker X8 Proteum
Absorption correctionMulti-scan (SADABS; Bruker, 2006)
T min, T max 0.850, 0.942
No. of measured, independent and observed [I > 2σ(I)] reflections11370, 3020, 3013
R int 0.032
(sin θ/λ)max−1)0.602
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.027, 0.068, 1.05
No. of reflections3020
No. of parameters220
No. of restraints1
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å−3)0.15, −0.14
Absolute structureFlack x determined using 1354 quotients [(I +)−(I )]/[(I +)+(I )] (Parsons et al., 2013).
Absolute structure parameter−0.04 (3)

Computer programs: APEX2 and SAINT (Bruker, 2006 ▸), SHELXS97, SHELXTL and XP in SHELXTL (Sheldrick, 2008 ▸), SHELXL2014 (Sheldrick, 2015 ▸) and CIFFIX (Parkin, 2013 ▸).

Refinement progress was checked using PLATON (Spek, 2009 ▸) and by an R-tensor (Parkin, 2000 ▸). Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S2056989015021507/zs2350sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015021507/zs2350Isup2.hkl CCDC reference: 1436825 Additional supporting information: crystallographic information; 3D view; checkCIF report
C19H22N2O3F(000) = 348
Mr = 326.38Dx = 1.273 Mg m3
Monoclinic, P21Cu Kα radiation, λ = 1.54178 Å
a = 10.3526 (2) ÅCell parameters from 9908 reflections
b = 7.2612 (1) Åθ = 4.5–68.2°
c = 11.9198 (2) ŵ = 0.70 mm1
β = 108.1210 (6)°T = 90 K
V = 851.60 (2) Å3Solvent-rounded block, colourless
Z = 20.25 × 0.13 × 0.10 mm
Bruker X8 Proteum diffractometer3020 independent reflections
Radiation source: fine-focus rotating anode3013 reflections with I > 2σ(I)
Detector resolution: 5.6 pixels mm-1Rint = 0.032
φ and ω scansθmax = 68.2°, θmin = 4.5°
Absorption correction: multi-scan (SADABS; Bruker, 2006)h = −12→10
Tmin = 0.850, Tmax = 0.942k = −8→8
11370 measured reflectionsl = −14→13
Refinement on F2Hydrogen site location: difference Fourier map
Least-squares matrix: fullH-atom parameters constrained
R[F2 > 2σ(F2)] = 0.027w = 1/[σ2(Fo2) + (0.0326P)2 + 0.1773P] where P = (Fo2 + 2Fc2)/3
wR(F2) = 0.068(Δ/σ)max < 0.001
S = 1.05Δρmax = 0.15 e Å3
3020 reflectionsΔρmin = −0.14 e Å3
220 parametersExtinction correction: SHELXL-2014, Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
1 restraintExtinction coefficient: 0.010 (2)
Primary atom site location: structure-invariant direct methodsAbsolute structure: Flack x determined using 1354 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et al., 2013).
Secondary atom site location: difference Fourier mapAbsolute structure parameter: −0.04 (3)
Experimental. The crystal was mounted with polyisobutene oil on the tip of a fine glass fibre, which was fastened in a copper mounting pin with electrical solder. It was placed directly into the cold gas stream of a liquid nitrogen based cryostat, according to published methods. Diffraction data were collected with the crystal at 90 K, which is standard practice in this laboratory for the majority of flash-cooled crystals.The crystals were large, and could not be cut to size without inducing damage by crushing, leading to shattered, frayed ends. These damaged parts could easily be dissolved away, however, to give solvent-rounded undamaged pieces of optimal size for data collection.
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement progress was checked using PLATON (Spek, 2009) and by an R-tensor (Parkin, 2000). The final model was further checked with the IUCr utility checkCIF.
xyzUiso*/Ueq
O10.59428 (12)0.24072 (19)0.48957 (10)0.0228 (3)
O20.30633 (12)0.25486 (17)0.43887 (10)0.0195 (3)
O30.12397 (13)0.29255 (19)0.49855 (11)0.0266 (3)
C10.57679 (17)0.5285 (2)0.19945 (14)0.0185 (4)
H1A0.58330.64390.23840.022*
C20.70386 (17)0.4134 (3)0.23289 (16)0.0208 (4)
H2A0.78090.48810.22570.025*
H2B0.69150.30760.17810.025*
C30.73676 (17)0.3417 (3)0.36116 (15)0.0202 (4)
H3A0.81460.25540.37920.024*
H3B0.76150.44600.41730.024*
C40.61322 (17)0.2447 (2)0.37345 (14)0.0178 (4)
C50.51035 (16)0.3615 (2)0.40010 (13)0.0165 (3)
H5A0.53530.49480.41180.020*
C60.35977 (16)0.3252 (2)0.34753 (14)0.0159 (3)
H6A0.34450.23210.28290.019*
C70.27894 (16)0.5036 (2)0.29783 (13)0.0149 (3)
H7A0.33960.61130.32920.018*
C80.22800 (16)0.5184 (3)0.16174 (14)0.0176 (4)
H8A0.14340.59230.13760.021*
H8B0.20580.39360.12780.021*
C90.33322 (17)0.6078 (3)0.11062 (14)0.0185 (4)
H9A0.28840.63580.02610.022*
H9B0.36380.72580.15190.022*
C100.45591 (17)0.4887 (2)0.12176 (14)0.0179 (4)
C110.16862 (16)0.5027 (2)0.35605 (14)0.0159 (3)
C120.19100 (17)0.3425 (3)0.43718 (14)0.0184 (4)
C130.06867 (17)0.6212 (3)0.35248 (14)0.0179 (4)
H13A0.00960.58720.39610.021*
C140.42876 (19)0.3267 (3)0.03864 (16)0.0269 (4)
H14A0.51400.26090.04730.040*
H14B0.39080.3705−0.04280.040*
H14C0.36390.24340.05730.040*
C150.57578 (18)0.0643 (2)0.30934 (18)0.0239 (4)
H15A0.50120.00720.33110.036*
H15B0.6548−0.01790.33120.036*
H15C0.54700.08610.22400.036*
C160.03901 (16)0.7977 (2)0.28928 (14)0.0180 (4)
C170.13568 (18)0.9097 (3)0.26601 (18)0.0244 (4)
H17A0.22810.87190.29330.029*
N180.10538 (16)1.0688 (2)0.20684 (16)0.0293 (4)
C19−0.02533 (19)1.1156 (3)0.17269 (17)0.0252 (4)
H19A−0.04851.22650.12870.030*
N20−0.12697 (15)1.0248 (2)0.19312 (14)0.0256 (4)
C21−0.09291 (18)0.8673 (3)0.25279 (15)0.0219 (4)
H21A−0.16210.79940.27130.026*
U11U22U33U12U13U23
O10.0188 (6)0.0306 (7)0.0176 (6)0.0061 (5)0.0035 (5)0.0092 (5)
O20.0187 (6)0.0200 (6)0.0221 (6)0.0038 (5)0.0098 (5)0.0064 (5)
O30.0242 (6)0.0305 (8)0.0303 (7)0.0031 (6)0.0162 (5)0.0097 (6)
C10.0218 (8)0.0163 (8)0.0197 (8)−0.0006 (7)0.0100 (7)0.0024 (7)
C20.0184 (8)0.0208 (9)0.0254 (9)−0.0018 (7)0.0101 (7)−0.0001 (7)
C30.0157 (8)0.0216 (9)0.0228 (8)0.0016 (7)0.0053 (6)−0.0004 (7)
C40.0163 (8)0.0184 (8)0.0174 (8)0.0036 (7)0.0031 (6)0.0040 (7)
C50.0175 (8)0.0173 (8)0.0141 (7)0.0020 (7)0.0043 (6)0.0031 (6)
C60.0173 (8)0.0162 (8)0.0154 (7)0.0002 (6)0.0068 (6)0.0012 (6)
C70.0155 (7)0.0147 (8)0.0142 (7)−0.0011 (6)0.0041 (6)−0.0008 (6)
C80.0172 (8)0.0201 (8)0.0143 (8)0.0005 (7)0.0034 (6)0.0003 (7)
C90.0209 (8)0.0195 (8)0.0147 (7)0.0018 (7)0.0051 (6)0.0044 (7)
C100.0221 (8)0.0190 (9)0.0150 (7)0.0003 (7)0.0092 (7)0.0026 (7)
C110.0153 (7)0.0170 (8)0.0143 (7)−0.0021 (7)0.0031 (6)−0.0010 (7)
C120.0166 (8)0.0206 (9)0.0187 (8)0.0004 (7)0.0065 (6)0.0014 (7)
C130.0144 (8)0.0213 (9)0.0175 (8)−0.0011 (7)0.0044 (6)−0.0018 (7)
C140.0258 (9)0.0321 (11)0.0219 (8)0.0041 (8)0.0061 (7)−0.0061 (8)
C150.0206 (8)0.0177 (9)0.0346 (10)0.0023 (7)0.0105 (8)0.0005 (7)
C160.0175 (8)0.0190 (9)0.0161 (7)0.0009 (7)0.0032 (6)−0.0044 (7)
C170.0156 (8)0.0189 (9)0.0350 (10)0.0005 (7)0.0024 (8)0.0019 (8)
N180.0209 (8)0.0216 (9)0.0409 (10)−0.0014 (6)0.0030 (7)0.0062 (7)
C190.0240 (9)0.0183 (9)0.0288 (9)0.0021 (8)0.0016 (7)0.0019 (8)
N200.0206 (8)0.0232 (8)0.0304 (8)0.0042 (6)0.0043 (6)0.0003 (7)
C210.0194 (8)0.0219 (9)0.0253 (9)0.0026 (7)0.0084 (7)−0.0024 (7)
O1—C51.444 (2)C8—H8B0.9900
O1—C41.457 (2)C9—C101.508 (2)
O2—C121.348 (2)C9—H9A0.9900
O2—C61.4585 (19)C9—H9B0.9900
O3—C121.210 (2)C10—C141.507 (3)
C1—C101.337 (2)C11—C131.336 (2)
C1—C21.504 (2)C11—C121.484 (2)
C1—H1A0.9500C13—C161.470 (2)
C2—C31.549 (2)C13—H13A0.9500
C2—H2A0.9900C14—H14A0.9800
C2—H2B0.9900C14—H14B0.9800
C3—C41.507 (2)C14—H14C0.9800
C3—H3A0.9900C15—H15A0.9800
C3—H3B0.9900C15—H15B0.9800
C4—C51.471 (2)C15—H15C0.9800
C4—C151.505 (3)C16—C171.383 (3)
C5—C61.511 (2)C16—C211.393 (2)
C5—H5A1.0000C17—N181.339 (2)
C6—C71.556 (2)C17—H17A0.9500
C6—H6A1.0000N18—C191.330 (2)
C7—C111.510 (2)C19—N201.327 (3)
C7—C81.546 (2)C19—H19A0.9500
C7—H7A1.0000N20—C211.335 (3)
C8—C91.547 (2)C21—H21A0.9500
C8—H8A0.9900
C5—O1—C460.94 (10)H8A—C8—H8B107.8
C12—O2—C6111.31 (12)C10—C9—C8113.70 (14)
C10—C1—C2128.05 (17)C10—C9—H9A108.8
C10—C1—H1A116.0C8—C9—H9A108.8
C2—C1—H1A116.0C10—C9—H9B108.8
C1—C2—C3110.73 (14)C8—C9—H9B108.8
C1—C2—H2A109.5H9A—C9—H9B107.7
C3—C2—H2A109.5C1—C10—C14124.58 (16)
C1—C2—H2B109.5C1—C10—C9121.22 (16)
C3—C2—H2B109.5C14—C10—C9114.20 (15)
H2A—C2—H2B108.1C13—C11—C12119.20 (15)
C4—C3—C2108.68 (14)C13—C11—C7132.19 (16)
C4—C3—H3A110.0C12—C11—C7108.42 (13)
C2—C3—H3A110.0O3—C12—O2121.43 (16)
C4—C3—H3B110.0O3—C12—C11128.78 (16)
C2—C3—H3B110.0O2—C12—C11109.75 (13)
H3A—C3—H3B108.3C11—C13—C16127.89 (16)
O1—C4—C559.08 (10)C11—C13—H13A116.1
O1—C4—C15112.05 (15)C16—C13—H13A116.1
C5—C4—C15121.46 (15)C10—C14—H14A109.5
O1—C4—C3118.08 (14)C10—C14—H14B109.5
C5—C4—C3116.40 (15)H14A—C14—H14B109.5
C15—C4—C3116.73 (15)C10—C14—H14C109.5
O1—C5—C459.97 (10)H14A—C14—H14C109.5
O1—C5—C6120.41 (14)H14B—C14—H14C109.5
C4—C5—C6122.16 (14)C4—C15—H15A109.5
O1—C5—H5A114.5C4—C15—H15B109.5
C4—C5—H5A114.5H15A—C15—H15B109.5
C6—C5—H5A114.5C4—C15—H15C109.5
O2—C6—C5109.48 (12)H15A—C15—H15C109.5
O2—C6—C7106.97 (12)H15B—C15—H15C109.5
C5—C6—C7112.07 (13)C17—C16—C21115.11 (16)
O2—C6—H6A109.4C17—C16—C13124.52 (15)
C5—C6—H6A109.4C21—C16—C13120.31 (15)
C7—C6—H6A109.4N18—C17—C16123.19 (16)
C11—C7—C8115.01 (13)N18—C17—H17A118.4
C11—C7—C6102.45 (13)C16—C17—H17A118.4
C8—C7—C6115.15 (13)C19—N18—C17115.52 (17)
C11—C7—H7A107.9N20—C19—N18127.34 (18)
C8—C7—H7A107.9N20—C19—H19A116.3
C6—C7—H7A107.9N18—C19—H19A116.3
C7—C8—C9112.99 (13)C19—N20—C21115.48 (15)
C7—C8—H8A109.0N20—C21—C16123.23 (17)
C9—C8—H8A109.0N20—C21—H21A118.4
C7—C8—H8B109.0C16—C21—H21A118.4
C9—C8—H8B109.0
C10—C1—C2—C3−110.99 (19)C2—C1—C10—C14−8.9 (3)
C1—C2—C3—C453.54 (19)C2—C1—C10—C9171.47 (16)
C5—O1—C4—C15−114.44 (16)C8—C9—C10—C1−107.23 (18)
C5—O1—C4—C3105.54 (17)C8—C9—C10—C1473.07 (19)
C2—C3—C4—O1−152.28 (15)C8—C7—C11—C13−56.5 (2)
C2—C3—C4—C5−84.95 (18)C6—C7—C11—C13177.78 (17)
C2—C3—C4—C1569.54 (18)C8—C7—C11—C12128.73 (15)
C4—O1—C5—C6111.94 (17)C6—C7—C11—C123.06 (16)
C15—C4—C5—O198.43 (17)C6—O2—C12—O3172.90 (16)
C3—C4—C5—O1−108.37 (16)C6—O2—C12—C11−9.33 (18)
O1—C4—C5—C6−109.10 (17)C13—C11—C12—O35.6 (3)
C15—C4—C5—C6−10.7 (2)C7—C11—C12—O3−178.86 (18)
C3—C4—C5—C6142.53 (15)C13—C11—C12—O2−171.94 (15)
C12—O2—C6—C5132.85 (14)C7—C11—C12—O23.59 (18)
C12—O2—C6—C711.21 (17)C12—C11—C13—C16172.57 (15)
O1—C5—C6—O236.7 (2)C7—C11—C13—C16−1.7 (3)
C4—C5—C6—O2108.24 (17)C11—C13—C16—C17−29.8 (3)
O1—C5—C6—C7155.20 (14)C11—C13—C16—C21153.17 (17)
C4—C5—C6—C7−133.25 (15)C21—C16—C17—N18−3.7 (3)
O2—C6—C7—C11−8.19 (16)C13—C16—C17—N18179.10 (17)
C5—C6—C7—C11−128.18 (14)C16—C17—N18—C191.1 (3)
O2—C6—C7—C8−133.78 (14)C17—N18—C19—N201.7 (3)
C5—C6—C7—C8106.23 (15)N18—C19—N20—C21−1.4 (3)
C11—C7—C8—C9153.12 (15)C19—N20—C21—C16−1.7 (3)
C6—C7—C8—C9−88.08 (18)C17—C16—C21—N204.0 (2)
C7—C8—C9—C1069.71 (19)C13—C16—C21—N20−178.66 (16)
  13 in total

1.  Expansion of scalar validation criteria to three dimensions: the R tensor

Authors: 
Journal:  Acta Crystallogr A       Date:  2000-03       Impact factor: 2.290

2.  The Cambridge Structural Database in retrospect and prospect.

Authors:  Colin R Groom; Frank H Allen
Journal:  Angew Chem Int Ed Engl       Date:  2014-01-02       Impact factor: 15.336

3.  Biomimetic transformations of parthenolide.

Authors:  J Castañeda-Acosta; N H Fischer; D Vargas
Journal:  J Nat Prod       Date:  1993-01       Impact factor: 4.050

4.  Semisynthetic derivatives of sesquiterpene lactones by palladium-catalyzed arylation of the alpha-methylene-gamma-lactone substructure.

Authors:  Changho Han; Francis J Barrios; Mark V Riofski; David A Colby
Journal:  J Org Chem       Date:  2009-09-18       Impact factor: 4.354

5.  An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.

Authors:  Monica L Guzman; Randall M Rossi; Sundar Neelakantan; Xiaojie Li; Cheryl A Corbett; Duane C Hassane; Michael W Becker; John M Bennett; Edmund Sullivan; Joshua L Lachowicz; Andrew Vaughan; Christopher J Sweeney; William Matthews; Martin Carroll; Jane L Liesveld; Peter A Crooks; Craig T Jordan
Journal:  Blood       Date:  2007-09-05       Impact factor: 22.113

6.  Antileukemic activity of aminoparthenolide analogs.

Authors:  Shama Nasim; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2008-06-19       Impact factor: 2.823

7.  Parthenolide specifically depletes histone deacetylase 1 protein and induces cell death through ataxia telangiectasia mutated.

Authors:  Y N Vashisht Gopal; Tarandeep S Arora; Michael W Van Dyke
Journal:  Chem Biol       Date:  2007-07

8.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

9.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20

10.  Crystal structure of (E)-13-{4-[(Z)-2-cyano-2-(3,4,5-tri-meth-oxy-phen-yl)ethen-yl]phen-yl}parthenolide methanol hemisolvate.

Authors:  Narsimha Reddy Penthala; Shobanbabu Bommagani; Venumadhav Janganati; Sean Parkin; Peter A Crooks
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.